The Biggest Startup Capital Raises - Week 40, 2026 (SEC Form D)

56 operating-company raises totalling $1.1B surfaced in SEC Form D filings (October 1-2, 2026). The top 10, ranked - days before the press.

Every week, companies quietly disclose fresh capital raises in SEC Form D filings - often days before (and frequently without) any press coverage. We pull the filings straight from EDGAR, filter out pooled investment funds (the hedge/PE/VC noise that makes up most Form D volume), and rank what is left: the real operating-company startup-funding signal.

This window (October 1-2, 2026): 56 qualifying raises, $1.1B in disclosed capital.

Top 10 by amount raised

# Company Sold to date Industry State Score
1 Lisata Therapeutics, INC. $351.9M Biotechnology NEW Jersey 100
2 General Intuition Holding B.V. $175.2M Other Technology Netherlands 97
3 Cscale, Inc. $145.0M Other Technology California 97
4 Frontier Z 1 LLC $70.0M Other Delaware 76
5 Click Therapeutics, Inc. $50.0M Other Health Care NEW YORK 83
6 PG EB5 Gatlinburg Lender, LLC $37.6M Other Real Estate Georgia 69
7 Amani Therapeutics, Inc. $35.0M Other Health Care NEW YORK 83
8 Zymochem, Inc. $25.1M Other Technology California 83
9 Evolution Metals & Technologies Corp. $22.0M Other Florida 75
10 Axle Labs, Inc. $17.3M Other Technology Georgia 75

Score = size × freshness × type (0-100). Every row in the full report links to the original SEC filing.

The headline raise: Lisata Therapeutics, INC.

Lisata Therapeutics, INC. reported $351.9M raised across 20 investors (Biotechnology, NEW Jersey). Disclosed executives / related persons include David Mazzo, James Nisco, Tariq IMAM. As always with Form D: amounts are self-reported by the issuer, and a filing is a disclosure - not an endorsement.

Get the full picture

Data source: official SEC EDGAR Form D. This is data and research, not investment advice.


Want the signal instead of the raw filings? Get the free Form D preview. Prefer the tool to the write-up? Browse all data feeds or connect the free MCP server.